RIFAMATE RIFAMATE (Rifamate 150 mg / 300 mg)

Generic Name: isoniazid/rifampin

Pill imprint RIFAMATE RIFAMATE has been identified as Rifamate 150 mg / 300 mg.

Rifamate is used in the treatment of tuberculosis, active and belongs to the drug class antituberculosis combinations. FDA has not classified the drug for risk during pregnancy. Rifamate 150 mg / 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for RIFAMATE RIFAMATE

Rifamate 150 mg / 300 mg RIFAMATE RIFAMATE
Rifamate
Generic Name:
isoniazid/rifampin
Imprint:
RIFAMATE
RIFAMATE
Strength:
150 mg / 300 mg
Color:
Red
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antituberculosis combinations
Pregnancy Category:
N - Not classified
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Aventis Pharmaceuticals
National Drug Code (NDC):
00068-0509
Inactive Ingredients:
silicon dioxide
FD&C Blue No. 1
FD&C Red No. 40
gelatin
magnesium stearate
sodium starch glycolate type A potato
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68258-9014 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)